CytomX Therapeutics, Inc. (CTMX) Social Stream



CytomX Therapeutics, Inc. (CTMX): $5.26

-0.18 (-3.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CytomX Therapeutics Inc (CTMX) Price Targets From Analysts

Use the tables below to see what analysts covering CytomX Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $18 $7 $13 $5.26 147.15%

The Trend in the Analyst Price Target


Over the past 15 months, CTMX's average price target has gone down $1.3.

CTMX reports an average of 85.38% for its upside potential over the past 15 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-09 8 18 7.0 13.00 5.17 151.45%
2021-09-04 8 18 7.0 13.00 5.14 152.92%
2021-08-28 8 18 7.0 13.00 5.19 150.48%
2021-08-02 8 18 7.0 12.94 5.61 130.66%
2021-08-01 8 18 7.0 12.94 5.41 139.19%
2021-07-24 8 18 7.0 12.94 5.55 133.15%
2021-07-17 8 18 7.0 12.94 5.79 123.49%
2021-07-10 8 18 7.0 12.94 6.07 113.18%
2021-07-03 8 18 7.0 12.94 6.24 107.37%
2021-06-21 8 18 7.0 12.94 7.05 83.55%
2021-06-13 8 18 7.0 12.94 7.16 80.73%
2021-06-05 8 18 7.0 12.94 6.77 91.14%
2021-05-19 8 18 8.5 13.19 8.23 60.27%
2021-04-30 8 18 8.5 13.19 9.36 40.92%
2021-04-25 8 18 8.5 13.19 9.16 44%
2021-04-17 8 18 8.5 13.19 7.51 75.63%
2021-04-01 8 18 8.5 13.19 7.87 67.6%
2021-03-20 8 18 8.5 12.56 8.27 51.87%
2021-03-13 8 18 8.5 12.56 8.50 47.76%
2021-03-05 8 18 8.5 12.56 7.78 61.44%
2021-02-15 8 18 8.5 12.56 9.00 39.56%
2021-02-13 8 18 8.5 12.56 9.00 39.56%
2021-02-06 8 18 8.5 12.56 8.04 56.22%
2021-01-30 8 18 8.5 12.56 6.91 81.77%
2021-01-23 8 18 8.5 12.56 6.65 88.87%
2021-01-16 8 18 8.5 12.56 7.93 58.39%
2021-01-09 8 18 8.5 12.56 7.40 69.73%
2021-01-02 8 18 8.5 12.56 6.55 91.76%
2020-12-10 8 18 8.5 12.56 7.27 72.76%
2020-12-07 8 18 8.5 12.56 7.27 72.76%
2020-11-28 8 18 8.5 12.56 7.42 69.27%
2020-11-06 8 18 8.5 12.56 7.02 78.92%
2020-10-29 8 18 8.5 12.94 6.77 91.14%
2020-09-14 9 18 8.5 13.17 NA NA%
2020-08-12 9 18 9.0 13.44 NA NA%
2020-08-07 9 18 9.0 13.44 NA NA%
2020-07-22 9 18 10.0 14.22 NA NA%
2020-07-13 9 18 10.0 14.22 NA NA%
2020-06-10 10 18 10.0 14.30 NA NA%

CTMX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.55 2 6 1 0 0 10

The Trend in the Broker Recommendations


CTMX's average broker recommendation rating worsened by 0.74 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTMX as an investment opportunity.

  • The variance in analysts' estimates of CTMX is lower than 7.83% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of CTMX is greater than 87.29% of all US stocks.
  • CytomX Therapeutics Inc's number of analysts covering the stock is greater than 94% of stocks in the small market cap category.
  • CTMX has a greater average analyst price target than 24.17% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CytomX Therapeutics Inc are SGMO, AKBA and OMER.

Is CTMX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8787 seconds.